Exploring Potential Treatment Targets: VEGF-C and D Signaling Pathways in Wet AMD
Tuesday, 9 July 2024, 13:56
Opthea's Latest Research: Targeting VEGF-C and D Signaling Pathways
Opthea's publication highlights the therapeutic potential of VEGF-C and D in treating Wet AMD, a prevalent eye condition.
Innovative Treatment Avenues
- VEGF-C and D Signaling: Identified as key pathways for potential treatment.
- Research Impact: Advancements in understanding AMD therapy.
Opthea's exploration brings new insights into combating Wet AMD, offering hope for improved treatment strategies.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.